Greg S. Martin

Epidemiology · 2003–2019

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Greg S. Martin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Derek C. Angus
  2. Jay S. Steingrub
  3. C. Zhan
  4. Jean-Louis Vincent

Who trusts Greg S. Martin overall

  1. T. Lagu
  2. M. Grabe
  3. Chris Paxton
  4. J. Guinea
  5. M. Delano
  6. M. Pfaller
  7. R. Hotchkiss

Papers from Greg S. Martin's perspective

Ordered by how strongly the researchers Greg S. Martin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  2. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging… (Journal of the American Medical Association (JAMA))
  3. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units (Intensive Care Medicine)
  4. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material (Intensive Care Medicine)
  5. Systemic inflammatory response syndrome criteria in defining severe sepsis. (New England Journal of Medicine)
  6. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. (Journal of the American Medical Association (JAMA))
  7. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
  8. APACHE II: A severity of disease classification system
  9. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
  10. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. (American Journal of Respiratory and Critical Care Medicine)

Their papers